NGEC Joins GBV Hearings, Amplifies Survivor Voices

The Commission (NGEC), led by CEO Dr. Purity Ngina, has reaffirmed its commitment to listening, learning, and acting in the national fight against GenderBased Violence (GBV).The Commission (NGEC), led by CEO Dr. Purity Ngina, has reaffirmed its commitment to listening, learning, and acting in the national fight against GenderBased Violence (GBV).

This comes as the Commission actively participates in the ongoing county hearings by the Technical Working Group on GBV, appointed by President William Ruto on January 10, 2025.

The 42-member Taskforce, constituted to curb the escalating cases of GBV and femicide in Kenya, was mandated to examine, assess, and review the country’s legal, policy, and institutional frameworks on GBV, and recommend actionable strategies for reform.

The national public participation exercise kicked off on Monday, May 12, and will run until Wednesday, May 28, covering all 47 counties.

Dr. Ngina, representing NGEC in this critical process, has already visited Embu, Murang’a, Nyeri, Kiambu, and Mandera counties. At each stop, the sessions placed communities at the center, providing a safe platform for survivors, local leaders, and residents to voice their experiences, concerns, and proposed solutions.

“Real change begins with the people,” emphasized Dr. Ngina. “We are here to listen to the lived realities of Kenyans and co-create sustainable, homegrown solutions to end GBV once and for all.” The hearings have revealed a strong public demand for coordinated action, increased awareness, and robust support systems. Survivors and community members are calling for strengthened legal mechanisms, survivor-centered services, and localized interventions to address the root causes of GBV.

As the hearings continue across the country, NGEC remains steadfast in amplifying community voices and influencing policy outcomes that promote equality, justice, and dignity for all.

NGEC CEO, Dr. Purity Ngina MBS, at the ongoing county hearings by the Technical Working Group on GBV